Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey

Table 3 Bivariable associations between taste, dose increased, supplements, pain, and dope sickness following a methadone formulation change

	Taste worsened		Dose increased		Began supplementing with opioids		More dope sick
	X²	Phi	X²	Phi	X²	Phi	X²	Phi
Dose increased	9.93**	0.20**
Began supplementing with opioids	3.99*	0.11*	21.50**	0.27**
More dope sick	22.52**	0.25**	13.70**	0.20**	70.63**	0.46**
More pain	22.23**	0.27**	13.06**	0.21**	29.43**	0.30**	77.28**	0.46**